Source: Annual Congress 2009 - Diagnosis and treatment of lung cancer
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
M. R. Loebinger, S. M. Janes (London, United Kingdom). Mesenchymal stem cells reduce lung metastases by controlled targeted delivery of TNF-related apoptosis-inducing ligand (TRAIL). Eur Respir J 2009; 34: Suppl. 53, 381

Member's Comments

No comment yet.

Related content which might interest you: Oral presentation: Mesenchymal stem cells reduce lung metastases by controlled targeted delivery of TNF-related apoptosis-inducing ligand (TRAIL) Source: Lung Science Conference 2009 - Cell proliferation, Differentiation and Carcinogenesis Year: 2009 Effects of chemotherapeutic drugs and TRAIL (tumor necrosis factor-related apoptosis inducing ligand) on the non-small lung cancer cells Source: Annual Congress 2009 - Treatment of lung cancer Year: 2009 The role of TNF-related apoptosis inducing ligand (TRAIL) in fibrotic lung disease Source: Annual Congress 2011 - Growth factors and fibrogenesis: are they good, bad or both? Year: 2011 Role of TNF-related apoptosis inducing ligand (TRAIL) in lung protective immunity against S. pneumoniae Source: Annual Congress 2010 - Mechanisms of respiratory infections Year: 2010 Alveolar recruited macrophages contribute to lung epithelial apoptosis and barrier dysfunction by expression of TNF-related apoptosis-inducing ligand during influenza virus pneumonia Source: Annual Congress 2008 - Border patrol: the alveolar barrier in lung injury Year: 2008 Gemcitabine sensitizes lung cancer cells to Fas /Fas ligand system-mediated killing Source: Annual Congress 2011 - Treatment of lung cancer Year: 2011 Macrophage released TNF-related apoptosis-inducing ligand (TRAIL) impairs alveolar fluid clearance after Influenza A virus infection Source: Lung Science Conference 2015 Year: 2015 Inhibition of proliferation of lung cancer cells by CD40 signaling through tumor necrosis factor I Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology Year: 2008 Mesenchymal stem cell based angiopoietin-1 gene therapy for acute lung injury induced by lipopolysacharride in mice Source: Annual Congress 2008 - Border patrol: the alveolar barrier in lung injury Year: 2008 Multipotent stromal cell-derived stanniocalcin-1 reduces reactive oxygen species and promotes survival of injured A549 lung cancer cells through upregulation of uncoupling-protein 2 and induction of the Warburg effect Source: Annual Congress 2010 - New insights into reactive oxygen species Year: 2010 Enhanced expression of Fas ligand (FasL) in fibrotic interstitial lung diseases (ILDs). The possible role of membrane-bound FasL form Source: Annual Congress 2011 - Genetic and molecular background in pulmonary fibrosis Year: 2011 The death receptor Fas in CD3+T cells in patients with non-small cell lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 673s Year: 2004 Contribution of genetic polymorphism of stromal cell-derived factor-1 (SDF-1) and its receptor, CXCR4, to the susceptibility and severity of non-small cell lung cancer Source: Annual Congress 2010 - Biomarkers for lung cancer Year: 2010 Blocking VEGF does not induce proapoptotic effects in the NSCLC cell line A549 Source: Annual Congress 2010 - New insights in the pathology of lung cancer Year: 2010 Mesenchymal stem cells reduce hypoxia-induced apoptosis in alveolar epithelial cells by modulating hypoxic signaling Source: International Congress 2015 – The multiple facets of stem and progenitor cells in lung health and disease Year: 2015 Resistance to Fas-mediated apoptosis in human lung fibroblast Source: Eur Respir J 2002; 20: 359-368 Year: 2002 NKG2D mediated cytotoxicity towards respiratory epithelial cells suggests a mechanism for lung injury following allogeneic stem cell transplantation Source: Annual Congress 2007 - Epithelial networks in the airways Year: 2007 Hypoxic lung cancer-derived exosome decreases anticancer activity of NK cell by targeting CD226 Source: International Congress 2019 – New molecular signatures in COPD, lung cancer and a1-antitrypsin deficiency Year: 2019 Mesenchymal stromal (stem) cell therapy modulates miR-193b-5p expression to attenuate sepsis-induced acute lung injury Source: Eur Respir J, 59 (1) 2004216; 10.1183/13993003.04216-2020 Year: 2022